IntelGenx Reports Q3 2022 Financial Results, Management Anticipates Psychedelics Trials In 2023

IntelGenx Technologies Corp. (TSX: IGX) (OTCQB: IGXT) reported its financial results late Thursday for the third quarter that ended September 30, 2022. Dr. Horst G. Zerbe, CEO of IntelGenx called the ...